Table 5.

An example 24-well plate setup for evaluating the ability of 12 candidate antidote oligonucleotides 1–12 (A1-A12) to reverse the binding of the E07 EGFR-targeting aptamer to EGFR on cells

	1	2	3	4	5	6
A	Cells alone	Cells + C36 nontargeting control	Cells + E07	Cells + A1 → E07	Cells + A2 → E07	Cells + A3 → E07
B	Cells + A4 → E07	Cells + A5 → E07	Cells + A6 → E07	Cells + A7 → E07	Cells + A8 → E07	Cells + A9 → E07
C	Cells + A10 → E07	Cells + A11 → E07	Cells + A12 → E07
D